These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21127768)

  • 1. Applying evidence-based device care in cardiovascular patients: which patient with heart failure and what device?
    Cleland JG; Buga L; Ghosh J; Nasir M
    J R Coll Physicians Edinb; 2010 Sep; 40(3):229-39. PubMed ID: 21127768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ongoing trials of cardiac resynchronisation.
    Cleland JG; Ghosh J; Khan N; Hurren S; Kaye G
    Minerva Cardioangiol; 2003 Apr; 51(2):197-207. PubMed ID: 12783075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac electronic implantable devices in the treatment of heart failure.
    Tan TC; Sindone AP; Denniss AR
    Heart Lung Circ; 2012 Jun; 21(6-7):338-51. PubMed ID: 22682103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arrhythmia risk stratification in patients with heart failure. Foreword].
    Opasich C; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy?
    Pieragnoli P; Ricciardi G; Colella A; Musilli N; Porciani MC; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2006 Dec; 54(6):735-41. PubMed ID: 17167385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac resynchronization therapy-always with ICD?].
    Stellbrink C
    Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure: the challenge of selecting patients for implantable cardioverter defibrillator therapy.
    Chandrasekaran B; Cowburn PJ
    Expert Rev Med Devices; 2010 Jul; 7(4):461-7. PubMed ID: 20583883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
    Ansalone G; Ricci R; Cacciatore G; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.
    Freeman JV; Masoudi FA
    Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Device therapy in heart failure patients with chronic kidney disease.
    Cannizzaro LA; Piccini JP; Patel UD; Hernandez AF
    J Am Coll Cardiol; 2011 Aug; 58(9):889-96. PubMed ID: 21851875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.